| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-15 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.4 | 3e-15 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.27 | 3e-13 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-13 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-12 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-11 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-10 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-10 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-08 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.3 | 1e-08 |